Targeting PIM kinase activity significantly augments the efficacy of cytarabine

Kevin R. Kelly, Claudia M. Espitia, Pietro Taverna, Gavin Choy, Swaminathan Padmanabhan, Steffan T. Nawrocki, Francis J. Giles, Jennifer S. Carew

Research output: Contribution to journalLetterpeer-review

18 Scopus citations
Original languageEnglish (US)
Pages (from-to)129-132
Number of pages4
JournalBritish Journal of Haematology
Volume156
Issue number1
DOIs
StatePublished - Jan 2012

Keywords

  • AML
  • Drug resistance
  • Leukaemia therapy
  • New drug development
  • New drugs for leukaemia

ASJC Scopus subject areas

  • Hematology

Cite this